• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查:传统与新一代粪便免疫化学检测方法的比较——粪便潜血试验的批判性回顾

Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.

机构信息

Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland.

Molecular Oncology of Research Center, Barretos Cancer Hospital, Barretos, Brazil.

出版信息

Anticancer Res. 2020 Feb;40(2):575-581. doi: 10.21873/anticanres.13987.

DOI:10.21873/anticanres.13987
PMID:32014898
Abstract

Previous randomized studies suggest that fecal occult blood test (FOBT) screening can reduce mortality from colorectal cancer (CRC). Our aim was to review the current status of FOBTs in CRC screening. FOB is measured using either the traditional guaiac-based tests or more recently introduced fecal immunochemical tests (FITs). FITs have several advantages over guaiac-based FOBTs, including higher sensitivity and specificity, resulting in improved clinical performance and higher efficiency. Another advantage in population screening according to European Guidelines for quality assurance in CRC screening is that FITs can be automated and user can adjust the cut-off at which a positive result is reported. In population-based screening, all those testing positively with any FOBT should be referred for colonoscopy. Conclusion: Although a plethora of FOBTs are available on the market, relatively few have been extensively tested for clinical sensitivity and specificity in CRC screening. Current data imply that new FITs have superior test characteristics as compared with guaiac-based FOBTs. The latest development in the field is represented by the proteomic-based tests that may further reduce false-negative rates in CRC screening. Simple stool sample preservation and automatic analysis are other important issues in population-based screening for CRC.

摘要

先前的随机研究表明,粪便潜血试验(FOBT)筛查可以降低结直肠癌(CRC)的死亡率。我们旨在回顾 FOBT 在 CRC 筛查中的现状。FOB 可使用传统的基于愈创木脂的检测方法或最近引入的粪便免疫化学检测(FIT)进行测量。FIT 相对于基于愈创木脂的 FOBT 具有几个优势,包括更高的敏感性和特异性,从而改善了临床性能和效率。根据欧洲 CRC 筛查质量保证指南,在人群筛查中另一个优势是 FIT 可以自动化,用户可以调整报告阳性结果的截止值。在基于人群的筛查中,所有用任何 FOBT 检测呈阳性的人都应转介进行结肠镜检查。结论:尽管市场上有大量的 FOBT,但相对较少的 FOBT 经过广泛测试以确定其在 CRC 筛查中的临床敏感性和特异性。目前的数据表明,新型 FIT 与基于愈创木脂的 FOBT 相比具有更好的测试特性。该领域的最新发展代表了基于蛋白质组学的检测方法,这可能进一步降低 CRC 筛查中的假阴性率。简单的粪便样本保存和自动分析是 CRC 人群筛查中的另一个重要问题。

相似文献

1
Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.结直肠癌筛查:传统与新一代粪便免疫化学检测方法的比较——粪便潜血试验的批判性回顾
Anticancer Res. 2020 Feb;40(2):575-581. doi: 10.21873/anticanres.13987.
2
Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.粪便潜血试验在结直肠癌筛查中的应用:传统和新一代粪便免疫化学试验的系统评价和荟萃分析。
Anticancer Res. 2020 Jul;40(7):3591-3604. doi: 10.21873/anticanres.14349.
3
A quantitative immunochemical fecal occult blood test for colorectal neoplasia.一种用于结直肠肿瘤的定量免疫化学粪便潜血试验。
Ann Intern Med. 2007 Feb 20;146(4):244-55. doi: 10.7326/0003-4819-146-4-200702200-00003.
4
Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.新一代粪便免疫化学检测(FIT)与愈创木脂粪便潜血试验(gFOBT)在结肠镜转诊患者中检测结直肠肿瘤的比较。
Anticancer Res. 2019 Jan;39(1):261-269. doi: 10.21873/anticanres.13106.
5
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.在筛查人群中对粪便潜血愈创木脂法检测和免疫化学法检测用于结直肠癌筛查的随机对照比较。
Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.
6
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.使用新型粪便潜血试验筛查结直肠肿瘤:性能特征的最新进展。
J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. doi: 10.1093/jnci/djm150. Epub 2007 Sep 25.
7
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].[用于结直肠癌筛查中粪便潜血检测的化学或免疫检测?]
Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3.
8
Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.在一项有组织的结直肠癌筛查计划中,免疫化学粪便潜血试验与愈创木脂粪便潜血试验的纵向依从性比较。
Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19.
9
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
10
Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review.用于结直肠癌筛查的粪便潜血试验的诊断准确性:一项系统评价。
J Med Screen. 2007;14(3):132-7. doi: 10.1258/096914107782066220.

引用本文的文献

1
Colorectal Cancer Detection Through Sweat Volatilome Using an Electronic Nose System and GC-MS Analysis.利用电子鼻系统和气相色谱-质谱联用分析通过汗液挥发物组检测结直肠癌
Cancers (Basel). 2025 Aug 23;17(17):2742. doi: 10.3390/cancers17172742.
2
Faecal occult blood testing: a review of its use and common misutilisation.粪便潜血检测:对其应用及常见误用情况的综述
BMJ Open Gastroenterol. 2025 Jul 17;12(1):e001876. doi: 10.1136/bmjgast-2025-001876.
3
Accuracy of Faecal Matrix-Metalloproteinase-9 (MMP-9) for Colorectal Cancer Detection in Makassar, Indonesia.
粪便基质金属蛋白酶-9(MMP-9)在印度尼西亚望加锡用于检测结直肠癌的准确性。
Asian Pac J Cancer Prev. 2025 Feb 1;26(2):603-609. doi: 10.31557/APJCP.2025.26.2.603.
4
Secretome and Proteome of Extracellular Vesicles Provide Protein Markers of Lung and Colorectal Cancer.细胞外囊泡的分泌蛋白组和蛋白质组提供肺癌和结直肠癌的蛋白质标志物。
Int J Mol Sci. 2025 Jan 25;26(3):1016. doi: 10.3390/ijms26031016.
5
Colorectal Cancer Screening and Management in Low- and Middle-Income Countries and High-Income Countries: A Narrative Review.低收入和中等收入国家以及高收入国家的结直肠癌筛查与管理:一项叙述性综述
Cureus. 2024 Oct 6;16(10):e70933. doi: 10.7759/cureus.70933. eCollection 2024 Oct.
6
Developing a Nomogram for Predicting Colorectal Cancer and Its Precancerous Lesions Based on Data from Three Non-Invasive Screening Tools, APCS, FIT, and sDNA.基于三项非侵入性筛查工具(APCS、FIT和sDNA)的数据开发预测结直肠癌及其癌前病变的列线图。
J Multidiscip Healthc. 2024 Jun 14;17:2891-2901. doi: 10.2147/JMDH.S465286. eCollection 2024.
7
Screening for colorectal cancer: Study on the shedding cells of feces.结直肠癌筛查:粪便脱落细胞研究
Cytojournal. 2024 Apr 25;21:16. doi: 10.25259/Cytojournal_107_2023. eCollection 2024.
8
Colorectal Cancer: Epidemiology, Risk Factors, and Prevention.结直肠癌:流行病学、风险因素与预防
Cancers (Basel). 2024 Apr 17;16(8):1530. doi: 10.3390/cancers16081530.
9
Cancer Screening: Present Recommendations, the Development of Multi-Cancer Early Development Tests, and the Prospect of Universal Cancer Screening.癌症筛查:当前建议、多癌早期检测试验的发展以及普遍癌症筛查的前景。
Cancers (Basel). 2024 Mar 18;16(6):1191. doi: 10.3390/cancers16061191.
10
National cancer screening program for colorectal cancer in Korea.韩国的国家结直肠癌筛查计划。
Ann Surg Treat Res. 2023 Dec;105(6):333-340. doi: 10.4174/astr.2023.105.6.333. Epub 2023 Nov 29.